Cardiac remodelling and RAS inhibition.

  • C. Ferrario
  • Published 2016 in Therapeutic advances in cardiovascular disease


Risk factors such as hypertension and diabetes are known to augment the activity and tissue expression of angiotensin II (Ang II), the major effector peptide of the renin-angiotensin system (RAS). Overstimulation of the RAS has been implicated in a chain of events that contribute to the pathogenesis of cardiovascular (CV) disease, including the development… (More)
DOI: 10.1177/1753944716642677


  • Presentations referencing similar topics